Trulieve Faces Lawsuit Over Employee Firings in Florida

Dec.14.2022
Trulieve Faces Lawsuit Over Employee Firings in Florida
Trulieve, a multi-state marijuana operator based in Florida, faces a collective lawsuit for allegedly not providing adequate notice prior to employee layoffs.

Trulieve, a multi-state cannabis operator headquartered in Florida, recently terminated some of its employees in Gadsden County. This resulted in affected workers filing a collective lawsuit alleging that the company did not provide sufficient notice before their termination.


Trulieve, a Florida-based cannabis company, operates two cultivation sites in Quincy and a processing plant on Midway Island in Gadsden County. The company has not disclosed the number of employees who have been terminated but has stated that the move is aimed at reducing layoffs as the company continues to grow, according to the Tallahassee Democrat.


According to Trulieve spokesperson Steve Vancore, affected employees have been offered alternative jobs at the company's other factories in Jefferson and Madison counties. Those employees who were ultimately not able to secure another position will receive severance pay.


Vancore informed Democratic lawmakers in Tallahassee that the layoffs ultimately stemmed from Trulieve's acquisition of Harvest Health and Recreation, which is based in Arizona.


We merged and acquired Harvest a year ago," Vancore told the news media. "This was part of our consolidation strategy as we continue to develop in areas of redundancy and inefficiency. When you have 9,000 employees, this is indeed a measure to improve efficiency.


Last week, employees affected by layoffs filed a class-action lawsuit against Trulieve, alleging that the company failed to provide the required Worker Adjustment and Retraining Notification (WARN) Act notice regarding their termination.


According to Democrats in Tallahassee, the lawsuit alleges that if a company lays off "50 or more employees (excluding any part-time employees) at a single worksite within any 30-day period," it must provide a notice under the WARN Act.


According to a report by the Tampa Bay Times, the lawsuit was originally filed by attorney Tiffany Cruz on behalf of Langel O'Neil, who worked at Trulieve's Quincy facility. The plaintiff is seeking monetary compensation equivalent to the total amount of unpaid wages, salaries, commissions, bonuses, accrued vacation pay, accrued sick pay, and other benefits within 60 days after termination. This has been reported in the media.


Trulieve has contested these allegations, according to Tallahassee attorney and partner at Stearns Weaver Miller, Glenn Burhans Jr., who told the news media that Trulieve "has complied with all state and federal laws regarding the reduction of force.


In possible scenarios, Trulieve offers affected employees new positions at the same location or other locations within the area," he told the Tampa Bay Times. "If relocation is not feasible or not accepted, employees will receive severance pay.


In another statement provided to the news media, Trulieve expressed its commitment to the northwest region of Florida and highlighted the construction of a 750,000-square-foot facility in Jefferson County by the company.


According to a statement released by the company to the Tampa Bay Times, Trulieve has approximately 9,000 employees in the United States and is currently hiring for "additional positions in various fields".



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
Philippines Weighs Unified Vape Tax as Lawmakers Back Risk-Based Rates and Government Seeks to Fill ₱66 Billion Revenue Gap
Philippines Weighs Unified Vape Tax as Lawmakers Back Risk-Based Rates and Government Seeks to Fill ₱66 Billion Revenue Gap
Philippine lawmakers are considering an overhaul of the country's vape excise-tax regime to eliminate the wide gap between taxes on nicotine salt and freebase nicotine liquids and reduce incentives for misdeclaration. House Bill 5364, filed by Rep. Rufus Rodriguez and Rep. Maximo Rodriguez Jr., would impose a unified ₱10-per-milliliter tax on vapor products, with 5% annual increases beginning in 2027. Rodriguez says the proposal could generate an average ₱6 billion in annual collections from 2027 through 2030. The debate comes as the Philippine government considers tobacco, vape and other health-tax reforms to help offset around ₱66 billion in revenue expected to be forgone under a proposed tax-relief package.
Aug.18
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
A new Swedish study found oral mucosal lesions in 79% of examined nicotine pouch users and 89% of tobacco-derived snus users, with different tissue-response patterns between the two categories. For manufacturers and regulators, the findings shift attention toward product formulation, flavouring, pouch materials and local oral exposure, not only whether a product contains tobacco. The study found no higher prevalence of caries or periodontal disease, but it could not establish causality, long-term outcomes or differences between individual products or designs.
Special Report
Jul.27
Product | JTI Expands Ploom Ecosystem as LYO Tobacco-Free Nicotine Sticks Roll Out Across Europe
Product | JTI Expands Ploom Ecosystem as LYO Tobacco-Free Nicotine Sticks Roll Out Across Europe
Japan Tobacco International (JTI) is expanding its Ploom heated product ecosystem with LYO tobacco-free nicotine sticks. Designed specifically for Ploom devices, LYO contains nicotine but no tobacco. Public information shows that the product has gradually entered several European markets, including Spain, Portugal and Germany, and was officially introduced in Romania in July 2026. The launch highlights JTI’s efforts to explore broader nicotine consumable formats beyond traditional tobacco-based sticks.
JTI
Jul.21 by 2Firsts Perspectives
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
R.J. Reynolds Vapor Company has introduced Vuse Pro prefilled pods in Peach, Berry, Watermelon and Fresh Mint in selected U.S. states. Vuse’s U.S. website says the pods are intended for use with existing Vuse Alto devices. Each contains 2.0 mL of e-liquid at 5.0% nicotine by weight, uses nicotine salts and is offered in two- and four-pod packs. Reynolds said the rollout includes mandatory ID scanning for every purchase, purchase limits, stronger retailer-accountability requirements and strict age-restricted marketing standards. The four pods have not received marketing authorization from the U.S. Food and Drug Administration.
Sep.10